Alleviare India Logo

FOTIVDA (Tivozanib) CAPSULE

Fotivda is a medicine used to treat adults with advanced renal cell carcinoma (kidney cancer).
Fotivda can be used in patients who have not been treated before, or who have worsened despite being treated with another drug that works in other ways. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma.

Fotivda is a medicine used to treat adults with advanced renal cell carcinoma (kidney cancer).

Fotivda can be used in patients who have not been treated before, or who have worsened despite being treated with another drug that works in other ways.

It contains the active substance tivozanib.

Fotivda (Tivozanib) Tablets suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Fotivda (Tivozanib) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Fotivda (Tivozanib) is manufactured by Pfizer.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Fotivda (Tivozanib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

FOTIVDA is indicated for the treatment of adult patients with refractory or refractory advanced renal cell carcinoma (RCC) after two or more prior systemic treatments. The recommended dose of FOTIVDA is 1.34 mg taken once daily for 21 days followed by 7 days of treatment for a cycle of 28 days.

Trade Name: Fotivda
Other Names: AV-951
Elimination half-life: 4.5-5.1 days
Protein binding: >99%
ATC code: L01EK03.

Dosage Forms & Strengths: capsule 0.89mg and 1.34mg.

fotivda

Fotivda is available.

Get In Touch

    FOTIVDA (Tivozanib) Tablets suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand FOTIVDA (Tivozanib) Capsules on prescription and Import License in Patient’s Name only.

    For foreign countries patients, FOTIVDA (Tivozanib) Capsules can be made available in Send your inquiry to find FOTIVDA (Tivozanib) Capsules in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for FOTIVDA (Tivozanib) Capsules

    For FOTIVDA (Tivozanib) Capsules Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details